CClinicalTrials.gg
CompletedNCT04833569Updated Apr 6, 2021

ICG-PDT, Periimplantitis, Diabetes Mellitus

A Phase 1 interventional study of ICG-PDT and peri-implant mechanical debridement in Peri-Implantitis, sponsored by King Saud University. Completed at 1 site in Saudi Arabia. Open to participants aged 45 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-04-06.

Sponsored by King Saud University · Phase 1, Interventional, and Treatment

From the registry’s dates

  • Registered 6 months after the study started (first participant enrolled Sep 2020, registered Mar 2021).
Phase
Phase 1
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
45 Years and older
Sex
All
01

Study summary

In this study, the effect of photodynamic therapy (indocyanine green mediated) on the clinical, biological and inflammatory aspects was assessed in diabetic patients having peri-implantitis

02

Conditions studied

  • Peri-Implantitis

Browse trials for

Keywords

  • photodynamic therapy*
  • periimplantitis*
  • diabetes mellitus*
  • indocyanine green*
  • photosensitizer*
03

In context

Peri-Implantitis

304 studies on the registry are indexed under Peri-Implantitis; 83 are open to participants now.

This study's enrollment of 50 is above the median of 40 across 182 interventional studies indexed under Peri-Implantitis.

Browse Peri-Implantitis studies →

Lead sponsor

King Saud University is the lead sponsor of 164 studies on the registry; 21 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
45 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

  • Inclusion Criteria:

    • adult patients above 45 years of age having type 2 DM
    • HbA1c (≥6.5%) and fasting glucose test
    • probing depth ≥6 mm with bleeding and/or suppuration on at least one site around dental implants that remained in situ
    • On radiographic assessment, the implants exhibited ≥ 3 mm alveolar bone loss apical to the coronal region of the intraosteal portion of the dental implant.
  • Exclusion Criteria Patients were excluded if they indicated current or former history of tobacco smoking, any systemic disease other than DM, enrolled in a non-surgical periodontal maintenance program, history of implant repair, pregnancy, and part six months use of antimicrobials, non-steroidal anti-inflammatory drugs, bisphosphonates, or corticosteroids.
05

Study design

Phase
Phase 1
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
50 participants (actual)

Study arms

  • Experimental
    Indocyanine green mediated photodynamic therapy (ICG-PDT)

    Delivery of ICG solution at a concentration of 1 mg/mL will be used. The photosensitizer will be applied until the bottom of the peri-implant pocket using a 1 ml syringe. An 810 nm diode laser (A.R.C. laser GmbH, Nurnberg, Germany) with a power of 200 mW (continuous mode) and total energy of 4 J will be used to excite the ICG by starting from the papilla for 30 s followed by the insertion inside the peri-implant pocket depth for 10 s from both buccal and lingual side moving to coronal direction.

    Biological: ICG-PDT · Device: peri-implant mechanical debridement

  • Placebo comparator
    Peri-implant mechanical debridement

    Non-surgical peri-implant mechanical debridement (PIMD) through ultrasonic device with a carbon tip.

    Device: peri-implant mechanical debridement

Interventions

  • BiologicalICG-PDT

    An 810 nm diode laser (A.R.C. laser GmbH, Nurnberg, Germany) with a power of 200 mW (continuous mode) and total energy of 4 J was used to excite the ICG by starting from the papilla for 30 s followed by the insertion inside the peri-implant pocket depth for 10 s from both buccal and lingual side moving to coronal direction. The treatment was applied according to the manufacturer's recommendation. The PDT was performed by a single operator in all test patients

  • Deviceperi-implant mechanical debridement

    The peri-implant mechanical debridement was done with the help of ultrasonic carbon tip (Vector, Durr Dental, Bietigheim-Bissingen, Germany).

06

What researchers measure

Primary outcomes

  1. Bleeding on probing

    Presence or absence of bleeding indicated as '1' or '0', respectively

    Time frame: 6 months

  2. Plaque index

    Presence or absence of plaque indicated as '1' or '0', respectively.

    Time frame: 6 months

  3. Probing depth

    Measurement of consecutive millimeter markings of the periodontal pocket depth

    Time frame: 6 months

  4. Suppuration

    Presence or absence of pus

    Time frame: 6 months

  5. Crestal bone loss

    Measurement of consecutive millimeter markings of the alveolar bone levels

    Time frame: 6 months

Secondary outcomes

  1. Microbiological analysis (Porphyromonas gingivalis)

    Bacterial viability from the peri-implant plaque

    Time frame: 6 months

  2. Microbiological analysis (Treponema denticola)

    Bacterial viability from the peri-implant plaque

    Time frame: 6 months

  3. HbA1c

    Assessment of serum HbA1c

    Time frame: 6 months

  4. Interleukin-1 beta

    Assessment from peri-implant crevicular fluid

    Time frame: 6 months

  5. Interleukin-6

    Assessment from peri-implant crevicular fluid

    Time frame: 6 months

07

Study locations

1 site
  • King Saud University
    Riyadh, 11564, Saudi Arabia
08

References and documents

Publications

  • Labban N, Shibani NA, Al-Kattan R, Alfouzan AF, Binrayes A, Assery MK. Clinical, bacterial, and inflammatory outcomes of indocyanine green-mediated photodynamic therapy for treating periimplantitis among diabetic patients: A randomized controlled clinical trial. Photodiagnosis Photodyn Ther. 2021 Sep;35:102350. doi: 10.1016/j.pdpdt.2021.102350. Epub 2021 May 24. PubMed 34033934 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 6, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04833569
Lead sponsor
King Saud University
Responsible party
Labban Nawwaf (Department of Prosthetic Dental Sciences, College of Dentistry, King Saud University, King Saud University) — Principal investigator
First posted
Apr 6, 2021
Start date
Sep 20, 2020
Primary completion
Feb 15, 2021
Completion
Mar 10, 2021
Last update
Apr 6, 2021

Study contacts

Nawwaf Labban, BDS MSD PhD
principal investigator · Department of Prosthetic Dental Sciences, College of Dentistry, King Saud University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion